121 drug-resistance analysis and prevention of MRSA in nenrosurgery intensive care unit
- VernacularTitle:颅脑创伤121例耐甲氧西林金黄色葡萄球菌的耐药性分析
- Author:
Yong LIU
;
Haijun YAO
;
Jin HU
;
Yanqun JIANG
;
Liangfu ZHOU
- Publication Type:Journal Article
- Keywords:
Craniocerebral trauma;
Staphylococcus aurens;
Drug resistance,bacterial
- From:
Chinese Journal of Primary Medicine and Pharmacy
2008;15(4):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To understand the drug-resistance of MRSA patients in neurosurgery intensive care unit,raise the prevention of MRSA and provide doctors the basis for controlling it. Methods The 5 year(20012005) MRSA patients were tested by Kirby-Bauer in neurosurgery intensive care unit of a third-tier general hospital in Shanghai. Statistic and analysis the drug-resistance of the patients. Results The rates of 121 MRSA drug-resistance to penicillin G,erythromycin, ciprofloxacin, amikacin and the cephalosporins are 92.3 % to 100 %, totally senaitire to teicoplanin and vancomycin and lower drug-resistance to rifampin,netilmicin and fosfomycin, but it rapidly raised from 10.0 % (2001 ) to 95.2 % (2005) to sulfamethoxazole. Conclusion It is time to take care of the drug-resistance of MRSA. Prevention and use antibiotics properly are the important ways to decrease the hospital infection and to improve the quality of recovered.
